Central Nervous System (CNS) / Neurocognitive Effects / Encephalopathy / HIV-related Dementia / Cerebrospinal Fluid (CSF)

(NE includes confusion, dizziness, stupor, agitation, amnesia, depersonalization, euphoria, hallucinations, insomnia, somnolence, abnormal thinking, impaired concentration, abnormal dreaming, and other related events)

HAART Appears to Halt HIV-related Brain Damage in HIV Patients - 10/12/07

Neurocognitive Problems in People with HIV May Persist Despite HAART    - 7/07/07

Severe Stress, Anxiety and Unusual Dreams May Reflect Persistent Central Nervous Toxicity of Efavirenz  1/19/07

HAART Suppresses HIV in Cerebrospinal Fluid More Than Plasma  1/16/07

Central Nervous System Toxicities and Efavirenz - 5/05/06

Effects of Perinatal HIV Infection on the Cognitive Development of Young Children - 4/18/06

Prediction of Neuropsychiatric Adverse Events Associated with Long-term Efavirenz Therapy Using Plasma Drug Level Monitoring - 10/28/05

Durable Virological Suppression Improves Survival in Neurocognitively Impaired Patients on HAART - 9/28/05

The Hidden Epidemic: Older Individuals with HIV Infection - 9/07/05

Undetectable HIV RNA and Beta-2 Microglobulin in Cerebrospinal Fluid Do Not Indicate Inactive AIDS Dementia Complex in Patients on HAART - 7/13/05

Neurocognitive Functioning in Pediatric HIV Infection: Effects of Combination Therapy - 7/11/05

Lopinavir Concentrations in Cerebrospinal Fluid Exceed the 50% Inhibitory Concentration for HIV - 5/27/05

Exercise Benefits the Heart and Nervous System of HIV Patients - 4/11/05

Sensorimotor Dysfunction: A Result of HIV Infection or an Effect of Antiretroviral Treatment and Comorbid Psychiatric Disorders? - 3/23/05

Which Offers the Greater Benefit: Immediate or Deferred Treatment for Central Nervous System-related Opportunistic Infections? - 3/23/05

Incidence and Prevalence of HIV Encephalopathy in HIV Positive Children Receiving HAART - 3/23/05

Kaletra Independently Reduces HIV Replication in Cerebrospinal Fluid and in the Brain - 3/04/05

Significance of JC Virus DNA Levels in Cerebrospinal Fluid of Patients with HIV-associated Progressive Multifocal Leukoencephalopathy (PML) - 2/14/05

HIV-associated Dementia Linked to Proviral DNA Levels - 2/11/05

Hyperlactatemia in HIV-negative Infants Who Are Exposed to Antiretrovirals - 12/13/04

Neuroactive HAART Helps Neuropsychologically Impaired HIV Patients - 12/10/04

Serotonin Receptor Antagonists May Treat JCV in AIDS Patients - 11/22/04

Remission of HIV-associated Myelopathy After HAART - 10/27/04

No Clinical Benefit Found with L-methionine Treatment of AIDS-associated Myelopathy  - 10/22/04

Long-term Virological Effect of HAART on Cerebrospinal Fluid and Relationship with Genotypic Resistance  - 10/18/04

HIV Infection Damages Dopamine-associated Brain Cells in Patients with HIV-related Dementia - 09/24/04

Depressive Symptoms, but Not Neurocognitive Impairment, Is Associated with Adherence to HAART - 09/17/04

Enhancing Therapy for HIV-related Cognitive Disorders - 09/15/04

Brain Attention Network May Be Altered in HIV Patients - 09/08/04

HIV-associated Neuromuscular Weakness Syndrome - 06/25/04

HAART Improves Neurocognitive Functioning  - 06/07/04

Lack of Lysozyme Tied to HIV Dementia  - 05/21/04

Ceramide Is Overproduced in HIV Dementia 3/12/04